1. Home
  2. ITOS vs BIOX Comparison

ITOS vs BIOX Comparison

Compare ITOS & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BIOX
  • Stock Information
  • Founded
  • ITOS 2011
  • BIOX 2001
  • Country
  • ITOS United States
  • BIOX Argentina
  • Employees
  • ITOS N/A
  • BIOX N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BIOX Agricultural Chemicals
  • Sector
  • ITOS Health Care
  • BIOX Industrials
  • Exchange
  • ITOS Nasdaq
  • BIOX Nasdaq
  • Market Cap
  • ITOS 270.7M
  • BIOX 275.1M
  • IPO Year
  • ITOS 2020
  • BIOX N/A
  • Fundamental
  • Price
  • ITOS $10.02
  • BIOX $4.88
  • Analyst Decision
  • ITOS Hold
  • BIOX Strong Buy
  • Analyst Count
  • ITOS 6
  • BIOX 4
  • Target Price
  • ITOS $10.60
  • BIOX $8.63
  • AVG Volume (30 Days)
  • ITOS 2.6M
  • BIOX 146.7K
  • Earning Date
  • ITOS 04-28-2025
  • BIOX 05-21-2025
  • Dividend Yield
  • ITOS N/A
  • BIOX N/A
  • EPS Growth
  • ITOS N/A
  • BIOX N/A
  • EPS
  • ITOS N/A
  • BIOX N/A
  • Revenue
  • ITOS $35,000,000.00
  • BIOX $383,293,344.00
  • Revenue This Year
  • ITOS N/A
  • BIOX N/A
  • Revenue Next Year
  • ITOS $31.74
  • BIOX $7.55
  • P/E Ratio
  • ITOS N/A
  • BIOX N/A
  • Revenue Growth
  • ITOS 177.89
  • BIOX N/A
  • 52 Week Low
  • ITOS $4.80
  • BIOX $3.51
  • 52 Week High
  • ITOS $18.13
  • BIOX $11.86
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 73.75
  • BIOX 57.04
  • Support Level
  • ITOS $8.30
  • BIOX $4.31
  • Resistance Level
  • ITOS $11.35
  • BIOX $5.18
  • Average True Range (ATR)
  • ITOS 0.53
  • BIOX 0.33
  • MACD
  • ITOS 0.22
  • BIOX 0.04
  • Stochastic Oscillator
  • ITOS 71.15
  • BIOX 65.90

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: